BEREN THERAPEUTICS
Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient. The company was founded in 2020 and is based in Bonn, Germany.
BEREN THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2020-01-01
Address:
Bonn, Nordrhein-Westfalen, Germany
Country:
Germany
Status:
Active
Similar Organizations
Albireo Pharma
Albireo Pharma a biotechnology company develops therapeutic drugs for gastrointestinal diseases.
Arktis Radiation Detectors
Arktis Radiation Detectors has developed a platform technology for detecting ionizing radiation using compressed noble gas.
Onward
Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
MitoRx Therapeutics
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
VIVAN Therapeutics
VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.
Outrun TX
Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.
SynaptixBio
SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.
Tally Health
Tally Health™ is a biotechnology company founded to change the way we age. Co-founded by longevity expert Dr. David Sinclair.
More informations about "Beren Therapeutics"
Beren Therapeutics - PitchBook
Beren Therapeutics was founded in 2020. Where is Beren Therapeutics headquartered? Beren Therapeutics is headquartered in Bonn, Germany. What industry is Beren Therapeutics in? Beren Therapeutics’s primary industry is …See details»
Beren Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Beren Therapeutics P.B.C - Press Release - Roquette
May 23, 2023 La Madeleine, France, and Thousand Oaks, CA, USA - May 23, 2023 – Roquette, a leading provider of pharmaceutical excipients and global leader in plant-based ingredients, is pleased to announce a strategic …See details»
BEREN THERAPEUTICS - Roquette
May 22, 2023 BEREN THERAPEUTICS PUBLIC PRESS RELEASE Roquette Announces Strategic Investment and Innovation Agreement with Beren Therapeutics P.B.C. La …See details»
Beren Therapeutics P.B.C. - Buzzfile
Beren Therapeutics P.B.C., which also operates under the name Beren Therapeutics, is located in Newbury Park, California. This organization primarily operates in the Biotechnical Research, …See details»
Beren Therapeutics P.B.C. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Beren Therapeutics P.B.C. of Newbury Park, CA. Get the latest business insights from Dun & …See details»
Beren Therapeutics - Updates, News, Events, Signals & Triggers
Beren Therapeutics is focused on developing therapies for cardiovascular diseases and cholesterol management. They are researching methods for treating atherosclerosis and …See details»
Beren Therapeutics (Beren Therapeutics) - 药物管线_专利_临床试 …
Mar 7, 2025 LA MADELEINE, France & THOUSAND OAKS, Calif.--(BUSINESS WIRE)-- Roquette, a leading provider of pharmaceutical excipients and global leader in plant-based …See details»
Beren Therapeutics - Crunchbase
Beren Therapeutics, Juventas Therapeutics, Marinomed, UVLrx Therapeutics, Amylon Therapeutics, and GamaMabs Pharma operate in the biotechnology and pharmaceutical …See details»
Beren Awarded Expedited Roadmap for Treatment of …
Nov 17, 2022 Beren Therapeutics, P.B.C. (Beren), a biotechnology company, today announced that its novel lead asset, BRN-002, was awarded an Innovation Passport unSee details»
Beren Therapeutics - Products, Competitors, Financials, Employees ...
Beren Awarded Expedited Roadmap for Treatment of Homozygous Familial Hypercholesterolemia. Nov 17, 2022. November 17, 2022 09:00 AM Eastern Standard Time …See details»
Roquette Announces Strategic Investment and Innovation …
May 23, 2023 Beren media contact Beren Patient and Community Engagement Cathy Traz [email protected] Roquette media contacts Roquette Global Pharmaceutical Business …See details»
beren therapeutics - EveryLife Foundation for Rare Diseases
A State Organization is structure for rare disease advocates in a state to gather to unite the community’s rare disease stakeholders. Its purpose is to increase awareness of the rare …See details»
BRN-002 - Drug Targets, Indications, Patents - Synapse
Mar 20, 2025 BRN-002, Initially developed by Beren Therapeutics PBC, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Endocrinology and Metabolic Disease,Other …See details»
Roquette Announces Strategic Investment and Innovation
May 23, 2023 LA MADELEINE, France & THOUSAND OAKS, Calif.--(BUSINESS WIRE)-- Roquette, a leading provider of pharmaceutical excipients and global leader in plant-based …See details»
Beren Awarded Expedited Roadmap for Treatment of …
Nov 17, 2022 WEST HOLLYWOOD, Calif.--(BUSINESS WIRE)-- Beren Therapeutics, P.B.C. (Beren), a biotechnology company, today announced that its novel lead asset, BRN-002, was …See details»
STRIDE: Semaglutide Shows It Has Legs in Peripheral Artery Disease
Mar 29, 2025 This makes semaglutide the first drug to show benefits in both cardiovascular outcomes and walking function, Bonaca said. Separately, in the SOUL trial of people with T2D …See details»
Roquette Announces Strategic Investment and Innovation …
May 23, 2023 Roquette, a leading provider of pharmaceutical excipients and global leader in plant-based ingredients, is pleased to announce a strategic investment with Beren …See details»
Merck KGaA to Acquire SpringWorks Therapeutics
5 days ago Merck KGaA will acquire SpringWorks Therapeutics, a US biopharmaceutical company focused on developing treatments for rare tumors. 1 According to a press release …See details»
Beren Awarded Expedited Roadmap for Treatment of …
Nov 18, 2022 WEST HOLLYWOOD, Calif.–(BUSINESS WIRE)–Beren Therapeutics, P.B.C. (Beren), a biotechnology company, today announced that its novel lead asset, BRN-002, was …See details»